Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1801–1850 of 35115
the Company’s Board of Directors (the “ Board ”) unanimously appointed Nancy Saitta and Leilani Bradford to serve as directors of the Company, to fill two newly created seats on the Board.
the Company’s Board of Directors (the “ Board ”) unanimously appointed Nancy Saitta and Leilani Bradford to serve as directors of the Company, to fill two newly created seats on the Board.
Effective as of April 27, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Arin Vahanian, Hao Shen and Joel A. Gallo.
Effective as of April 27, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Arin Vahanian, Hao Shen and Joel A. Gallo.
Effective as of April 27, 2026, the following individuals were appointed to the board of directors (the “Board”) of the Company: Arin Vahanian, Hao Shen and Joel A. Gallo.
appointed Jim S. Holotik to serve as a director on the board of directors of the General Partner
the board of directors (our Board) of Health Catalyst, Inc. (the Company), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Steven Nelson to the Board, effective May 1, 2026.
Daniel Hennessy resigned from the Board and the Company's other committees effective as of April 29, 2026.
On April 29, 2026, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed John Hewitt to fill the vacancy created by Mr. Hennessy's resignation, effective April 29, 2026.
FMC Corporation (the “ Company ”) announced the passing of Dirk A. Kempthorne, a member of our board of directors (the “ Board ”) since 2009.
Suketu Upadhyay informed the board of directors (the "Board") of Vertex Pharmaceuticals Incorporated (the "Company") of his decision not to stand for re-election as a director of the Company at the Company’s 2026 annual meeting of shareholders (the "2026 Annual Meeting").
the board of directors of each of the Company and Hawthorn Bank increased their respective sizes by one member, and appointed Grant T. Burcham to serve on both the Company's and Hawthorn Bank's board of directors to fill such newly created vacancies, in each case, effective April 29, 2026.
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
Paul Adams, Kirk S. Hachigian and Larry A. Lawson were appointed to the board of directors of the Company (the “Board”).
On April 24, 2026, the board of directors (the “Board”) of Forward Air Corporation (the “Company”) received notice from Charles L. Anderson and Robert L. Edwards, Jr. that each will not be standing for re-election at the Company’s annual meeting of stockholders to be held on June 17, 2026 (the “2026 Annual Meeting”).
On April 24, 2026, the board of directors (the “Board”) of Forward Air Corporation (the “Company”) received notice from Charles L. Anderson and Robert L. Edwards, Jr. that each will not be standing for re-election at the Company’s annual meeting of stockholders to be held on June 17, 2026 (the “2026 Annual Meeting”).
On April 24, 2026, both William R. Jellison, a Class I member of the Board of Directors (the "Board") of the Company, and Glenn R. Larsen, Ph.D., a Class II member of the Board, notified the Board of their resignation from the Board, including from all committees on which each serves effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
On April 24, 2026, both William R. Jellison, a Class I member of the Board of Directors (the "Board") of the Company, and Glenn R. Larsen, Ph.D., a Class II member of the Board, notified the Board of their resignation from the Board, including from all committees on which each serves effective as of the Company's 2026 annual meeting of stockholders (the "2026 Annual Meeting").
Effective April 24, 2026, the Board of Directors of the Company (the "Board") appointed Marc James to serve as a Class II Director of the Board for the remainder of the term of Class II Directors of the Board, expiring at the 2026 Annual Meeting of Shareholders of the Company.
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
Eli Wallace, Ph.D. resigned from his position as a member of the Company’s Board of Directors and as a Class III director, and was succeeded by Pedro J. Beltran, Ph.D. in these positions and as the Company’s President and Chief Executive Officer, effective on April 20, 2026.
The Board has nominated Martin Babler and Troy Cox as Class I director nominees to replace Dr. Malenka and Dr. Trenkle.
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.
The Board has nominated Martin Babler and Troy Cox as Class I director nominees to replace Dr. Malenka and Dr. Trenkle.
On April 23, 2026, Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of Directors (the "Board") of MapLight Therapeutics, Inc. (the "Company") of their respective decisions not to stand for reelection at the Company’s Annual Meeting of Stockholders to be held on June 23, 2026.
the Board appointed Dr. Prakash Raman to the Board as a Class II director, effective April 28, 2026
On April 27, 2026, in connection with the IPO, William Sherman was appointed to the board of directors of the Company (the “ Board ”) effective April 28, 2026.
the Board increased the authorized number of directors to five and appointed Lazar to the Board to fill the vacancy created by such increase, effective immediately
Bharat Vasan notified the Board of Directors of Starco Brands, Inc. (the “Company”), that he resigns from the Board of Directors, effective April 27, 2026.
On April 23, 2026, Neeraj Agrawal notified the Board that he will not stand for re-election as a Class II director of the Company at the 2026 Annual Meeting.
On April 23, 2026, Yvette Kanouff notified the board of directors (the “Board”) of Sprinklr, Inc. (the “Company”) that she will not stand for re-election as a Class II director of the Company at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).
On April 26, 2026, Diane Bryant resigned as a member of the Board of Directors of Jacobs Solutions Inc. (the “Company”).
On April 23, 2026, the Board of Directors of XPEL, Inc. (the “Company) appointed Mark Thornton to the Board of Directors of the Company.
F. Brooks Bertsch resigned from the Board pursuant to the terms of the Stock Repurchase Agreement.
On April 24, 2026, Steve Tyink resigned from his director and committee positions at EWSB Bancorp, Inc. (the “Company”) and East Wisconsin Savings Bank (the “Bank”) in order to focus on personal matters, effective on that date.
On April 24, 2026, the Board of Directors (the “Board”) of F5, Inc. (the “Company”) appointed Mr. Anand Eswaran as a director.
On April 23, 2026, the Board of Directors of Hilltop Holdings Inc., or the Company, appointed Dana Bober and Stephen Haworth as directors of the Company.
On April 23, 2026, the Board of Directors of Hilltop Holdings Inc., or the Company, appointed Dana Bober and Stephen Haworth as directors of the Company.
voted to (i) remove Dr. Joanna Massey, Donna Grier, Aron Schwartz, and Shawn Canter from the board of directors of the Company effective immediately
voted to (i) remove Dr. Joanna Massey, Donna Grier, Aron Schwartz, and Shawn Canter from the board of directors of the Company effective immediately
elect Benjamin Andrew Frank and Dr. Michael Philip Kimel as members of the board of directors of the Company to serve until the next annual meeting of stockholders of the Company or until their successors have been duly elected and qualified, effective immediately
voted to (i) remove Dr. Joanna Massey, Donna Grier, Aron Schwartz, and Shawn Canter from the board of directors of the Company effective immediately
voted to (i) remove Dr. Joanna Massey, Donna Grier, Aron Schwartz, and Shawn Canter from the board of directors of the Company effective immediately
elect Benjamin Andrew Frank and Dr. Michael Philip Kimel as members of the board of directors of the Company to serve until the next annual meeting of stockholders of the Company or until their successors have been duly elected and qualified, effective immediately
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
Rami Elghandour, David Lubner, Kavita Patel, Olivia Ware, Ali Behbahani, Jill Carroll, Andrew Galligan, and Kristin Myers, being all of the directors of the Company immediately prior to the Effective Time, resigned and ceased to be directors of the Company as of the Effective Time.
the directors and officers of Purchaser as of immediately prior to the Effective Time, which consisted of Andrew D. Dickinson, Keeley Cain Wettan, and Thomas Kennedy, became the directors and officers of the Company.
the directors and officers of Purchaser as of immediately prior to the Effective Time, which consisted of Andrew D. Dickinson, Keeley Cain Wettan, and Thomas Kennedy, became the directors and officers of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.